DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Biosimilars


Roche’s Gazyva Misses Lymphoma Target

20.07.2016 - Roche’s new blood cancer drug Gazyva has failed to show significant improvements in a late-stage lymphoma trial, delivering a blow to its plans for a successor to blockbuster drug...


Sandoz to Launch Five Biosimilars by 2020

21.06.2016 - Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to launch five biosimilars of major oncology and immunology biologics across key global markets by 2020...

Markets & Companies

After Pharma’s Patent Cliff

04.04.2016 - Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...


NICE Approves Two Biosimilars for Arthritis

02.02.2016 - Rheumatoid arthritis sufferers in England will soon be able to benefit from a cheaper generic version of US pharmaceutical producer Merck’s and the world’s best-selling medicines...


Global Data Sees Indian Generics Soaring

29.01.2016 - The value of the Indian pharmaceutical market is set to nearly quadruple over the next five years, soaring from $20 billion in 2015 to $55 billion by 2020, according to GlobalData...

Strategy & Management

Bio On Demand

07.10.2015 - The ability to rapidly deploy manufacturing capacity will be a strategic asset of the pharmaceutical industry in the future. NNE Pharmaplan has developed the “Bio on demand”...

Plant Construction & Process Technology

Growth Amid Risk

07.10.2015 - Interest in the biopharma industry continues to grow, making the development and manufacturing services of the biologic entities for both drug substance and drug product a more...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.